Description 

Psychiatric disorders are increasingly understood as similar to medical illnesses. Most have a genetic etiology, are complex conditions and difficult to treat. Over the long term, for most patients they are chronic or recurrent. Over the last four decades, the field of psychiatry, using randomized, controlled research studies has found treatments with similar efficacy like other fields of medicine for most psychiatric disorders.   Psychopharmacologic treatments have become a central part of integrated psychiatric practice. This research has mostly focused on early intervention or acute effects of medication. Longer-term studies have been much less common. In this symposium, we will present a summary of such research on long-term treatment of 1) anxiety disorders, 2) depressive disorders, and 3) schizophrenia. We present outcome data suggesting that for most patients, long-term, lifetime management/treatment is indicated in combination with other psychosocial and psychobiological interventions.   All three disorders, Anxiety Disorders, Major Depressive Disorder (MDD), and Schizophrenia are complex, heterogeneous disorders with multiple biological, psychological, and sociocultural determinants, risk factors and treatment approaches. In this session, we will present long-term management and treatment guidelines both from the literature and from our clinical experience.

Format 

Recorded webinar.

This content was recorded during the APA 2023 Annual Meeting.

Learning Objectives 

1. At the conclusion of this session, participants will be aware of how to integrate their skills into clinical practice on management and long-term treatment of anxiety disorders.
2. At the conclusion of this session, participants will be aware of how to integrate their skills into clinical practice on management and long-term treatment of depressive disorders.
3. At the conclusion of this session, participants will be aware of how to integrate their skills into clinical practice on management and long-term treatment of schizophrenia.

Target Audience 

Residents/Fellows, Psychiatrists, Psychologists

Estimate Time to Complete 

Estimated Duration: 1.5 hours
Program Start Date: May 1, 2025
Program End Date: May 1, 2028

How to Earn Credit 

Participants who wish to earn AMA PRA Category 1 Credit™ may do so after completing all sections of the course including the evaluation. After evaluating the program, course participants will be provided with an opportunity to claim hours of participation and print an official CME certificate (physicians) or certificate of participation (non-physicians) showing the completion date and hours earned. 

Continuing Education Credit  

In support of improving patient care, the American Psychiatric Association is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. 

The APA designates this live activity for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. 

Faculty and Planner Disclosures 

The American Psychiatric Association adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Medical Education. Any individuals in a position to control the content of a CME activity — including faculty, planners, reviewers or others — are required to disclose all relevant financial relationships with ineligible entities (commercial interests). All relevant conflicts of interest have been mitigated prior to the commencement of the activity. 

Instructors 

• Ira Glick, MD
• Carl Salzman, MD
• Sidney Zisook, MD

Planners  

• Vishal Madaan, MD, Chief of Education and Deputy Medical Director at the American Psychiatric Association.

Accessibility for Participants with Disabilities 

The American Psychiatric Association is committed to ensuring accessibility of its website to people with disabilities. Please contact the American Psychiatric Association at 202-559-3900, if you require assistance seven (7) business days prior to the start of a live webinar. 

Technical Requirements 

This internet-based CME activity is best experienced using any of the following: 

• The latest and 2nd latest public versions of Google Chrome, Mozilla Firefox, or Safari 
• Internet Explorer 11+ 

This Web site requires that JavaScript and session cookies be enabled. Certain activities may require additional software to view multimedia, presentation, or printable versions of the content. These activities will be marked as such and will provide links to the required software. That software may be: Adobe Acrobat Reader, Microsoft PowerPoint, and Windows Media Player. 

Optimal System Configuration: 

• Browser: Google Chrome (latest and 2nd latest version), Safari (latest and 2nd latest version), Internet Explorer 11.0+, Firefox (latest and 2nd latest version), or Microsoft Edge (latest and 2nd latest version) 
• Operating System: Windows versions 8.1+, Mac OS X 10.5 (Leopard) +, Android (latest and 2nd latest version), or iOS/iPad OS (latest and 2nd latest version) 
• Internet Connection: 1 Mbps or higher 

Minimum Requirements: 

• Windows PC: Windows 8.1 or higher; 1 GB (for 32-bit)/2 GB (for 64-bit) or higher RAM; Microsoft DirectX 9 graphics device with WDDM driver; audio playback with speakers for programs with video content 
• Macintosh: Mac OS X 10.5 or higher with latest updates installed; Intel, PowerPC G5, or PowerPC G4 (867MHz or faster) processor; 512 MB or higher RAM; audio playback with speakers for programs with video content 

For assistance: Contact educme@psych.org for questions about this activity | Contact learningcenter@psych.org for technical assistance